NO996117L - Device for administering medications and treating viral and microbial infections and taering syndrome - Google Patents

Device for administering medications and treating viral and microbial infections and taering syndrome

Info

Publication number
NO996117L
NO996117L NO996117A NO996117A NO996117L NO 996117 L NO996117 L NO 996117L NO 996117 A NO996117 A NO 996117A NO 996117 A NO996117 A NO 996117A NO 996117 L NO996117 L NO 996117L
Authority
NO
Norway
Prior art keywords
microbial infections
syndrome
taering
treating viral
administering medications
Prior art date
Application number
NO996117A
Other languages
Norwegian (no)
Other versions
NO996117D0 (en
Inventor
Michelle Olga Patricia Visser
Original Assignee
Cryopreservation Tech Cc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/874,425 external-priority patent/US5935597A/en
Application filed by Cryopreservation Tech Cc filed Critical Cryopreservation Tech Cc
Publication of NO996117D0 publication Critical patent/NO996117D0/en
Publication of NO996117L publication Critical patent/NO996117L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10—Sulfides; Sulfoxides; Sulfones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/164—Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4412—Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Abstract

Nye medikamentavleveringsanordninger, fremgangsmåter og terapeutiske sammensetninger er beskrevet for behandling av virale og mikrobielle infeksjoner og tæringssyndrom i dyr, innbefattende mennesker. Det er beskrevet å administrere til en pasient i behov for behandling en polar forbindelse så som dimetylformamid eller dimetylsulfoksid, fortrinnsvis via en transdermal rute. Det er videre beskrevet en vaksine fremstilt fra antistoff innhøstet fra legemet hos en pasi- ent behandlet ved fremgangsmåten for en viral infeksjon.New drug delivery devices, methods and therapeutic compositions have been described for the treatment of viral and microbial infections and coronary syndrome in animals, including humans. It is disclosed to administer to a patient in need of treatment a polar compound such as dimethylformamide or dimethyl sulfoxide, preferably via a transdermal route. A vaccine prepared from antibody harvested from the body of a patient treated by the method of a viral infection is further described.

NO996117A 1997-06-13 1999-12-10 Device for administering medications and treating viral and microbial infections and taering syndrome NO996117L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/874,425 US5935597A (en) 1995-12-15 1997-06-13 Drug delivery devices and methods for treatment of viral and microbial infections and wasting syndromes
PCT/US1998/011956 WO1998056325A1 (en) 1997-06-13 1998-06-09 Drug delivery devices and methods for treatment of viral and microbial infections and wasting syndromes

Publications (2)

Publication Number Publication Date
NO996117D0 NO996117D0 (en) 1999-12-10
NO996117L true NO996117L (en) 2000-02-11

Family

ID=25363728

Family Applications (1)

Application Number Title Priority Date Filing Date
NO996117A NO996117L (en) 1997-06-13 1999-12-10 Device for administering medications and treating viral and microbial infections and taering syndrome

Country Status (34)

Country Link
EP (1) EP1011567A1 (en)
JP (1) JP4531141B2 (en)
KR (1) KR20010013709A (en)
CN (1) CN1260703A (en)
AP (1) AP1629A (en)
AR (1) AR012970A1 (en)
AU (1) AU7831598A (en)
BG (1) BG103997A (en)
BR (1) BR9810095A (en)
CA (1) CA2295176A1 (en)
CZ (1) CZ298510B6 (en)
EA (1) EA200000011A1 (en)
EE (1) EE9900562A (en)
ES (1) ES2161187B1 (en)
FI (1) FI19992648A (en)
GB (1) GB2341319B (en)
HU (1) HUP0003034A2 (en)
ID (1) ID23516A (en)
IL (2) IL133396A0 (en)
IS (1) IS5289A (en)
LT (1) LT4714B (en)
LV (1) LV12490B (en)
NO (1) NO996117L (en)
NZ (1) NZ501669A (en)
OA (1) OA11307A (en)
PL (1) PL196256B1 (en)
RO (1) RO121252B1 (en)
SI (1) SI20191A (en)
SK (1) SK172299A3 (en)
TN (1) TNSN98086A1 (en)
TR (1) TR200000540T2 (en)
WO (1) WO1998056325A1 (en)
YU (1) YU66099A (en)
ZA (1) ZA984649B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070212402A1 (en) * 2003-12-05 2007-09-13 Rooven Qainton V Patch

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE60941B1 (en) * 1986-07-10 1994-09-07 Elan Transdermal Ltd Transdermal drug delivery device
US4855294A (en) * 1988-09-06 1989-08-08 Theratech, Inc. Method for reducing skin irritation associated with drug/penetration enhancer compositions
US5534260A (en) * 1989-02-23 1996-07-09 University Of Utah Percutaneous drug delivery system
US5028435A (en) * 1989-05-22 1991-07-02 Advanced Polymer Systems, Inc. System and method for transdermal drug delivery
US5624912A (en) * 1991-08-21 1997-04-29 Burcoglu; Arsinur Method of treating HIV infection and related secondary infections with defibrotide
KR100275843B1 (en) * 1992-02-20 2000-12-15 슈테펜엘.네스비트 Sulfonic acid derivatives and pharmacuetical composition containing the same
EE9800176A (en) * 1995-12-15 1998-12-15 Cryopreservation Technologies Cc Composition for cold storage of organs and treatment of viral and bacterial infections

Also Published As

Publication number Publication date
ES2161187B1 (en) 2003-08-16
SI20191A (en) 2000-10-31
EE9900562A (en) 2000-06-15
IS5289A (en) 1999-12-08
CZ9904473A3 (en) 2001-03-14
FI19992648A (en) 2000-02-03
EP1011567A4 (en) 2000-06-28
HUP0003034A2 (en) 2000-12-28
AP1629A (en) 2006-07-11
EA200000011A1 (en) 2000-08-28
TR200000540T2 (en) 2000-09-21
NZ501669A (en) 2001-09-28
TNSN98086A1 (en) 2005-03-15
EP1011567A1 (en) 2000-06-28
BR9810095A (en) 2001-11-13
BG103997A (en) 2001-07-31
LV12490B (en) 2000-12-20
PL338439A1 (en) 2000-11-06
NO996117D0 (en) 1999-12-10
AU7831598A (en) 1998-12-30
AR012970A1 (en) 2000-11-22
AP9901708A0 (en) 1999-12-31
LT99148A (en) 2000-07-25
PL196256B1 (en) 2007-12-31
ID23516A (en) 2000-04-27
WO1998056325A1 (en) 1998-12-17
OA11307A (en) 2003-10-24
RO121252B1 (en) 2007-02-28
LT4714B (en) 2000-10-25
CN1260703A (en) 2000-07-19
YU66099A (en) 2002-10-18
LV12490A (en) 2000-06-20
KR20010013709A (en) 2001-02-26
IL133396A0 (en) 2001-04-30
JP4531141B2 (en) 2010-08-25
GB9929189D0 (en) 2000-02-02
IL133396A (en) 2006-10-05
ZA984649B (en) 1999-12-17
GB2341319A (en) 2000-03-15
ES2161187A1 (en) 2001-11-16
JP2002511862A (en) 2002-04-16
GB2341319B (en) 2002-02-27
SK172299A3 (en) 2000-09-12
CZ298510B6 (en) 2007-10-24
CA2295176A1 (en) 1998-12-17

Similar Documents

Publication Publication Date Title
JP6382798B2 (en) Topical non-aqueous pharmaceutical formulation
DE60036456D1 (en) ANTIMICROBIAL EFFECTIVE OR ENDOTOXIN NEUTRALIZING POLYPEPTIDE
KR910700048A (en) Use of omeprazole as an antibacterial agent
CY1116463T1 (en) Combination therapy for the therapeutic treatment of Protein Deficiency Disorders
DE60331537D1 (en) COMBINATIONS FOR THE TREATMENT OF MULTIPLE MYELOMA
DE69232263T2 (en) RADICAL RECIPIENT ("SPIN TRAPS") FOR TREATING ILLNESSES ASSOCIATED WITH OXIDATION OF LIPIDES AND PROTEINS
DE69433901D1 (en) COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS FOR TREATING AND PROPHYLAXIS OF BACTERIAL INFECTIONS
WO2005009961B1 (en) Fluoro substituted omega-carboxyaryl diphenyl urea for the treatment and prevention of diseases and conditions
NO20061325L (en) Combination of drugs for the treatment of neoplasms
NO20045240L (en) Transepicutaneous administration to treat restless legs syndrome
ATE399562T1 (en) USE OF MILK SERUM APOPROTEINS IN PROPHYLAXIS OR TREATMENT OF MICROBIAL OR VIRUS INFECTIONS
DE60331412D1 (en) HIV vaccine and method of administration
DE60018409D1 (en) USE OF ANTISEPTICA FOR THE PREPARATION OF MEDICAMENTS FOR THE PROPHYLAXIS AND THE TREATMENT OF INFECTIONS AND / OR FUNCTIONAL TISSUE FORMATIONS IN THE BODY'S INSECTS
CY1105545T1 (en) STATIN THERAPY TO ENHANCE THE PRESERVATION OF MENTAL FUNCTION
BR0206869A (en) method for treating an animal suffering from a disease state of immune dysfunction associated with altered levels of igg or tnf-delta, a pharmaceutical composition for treating autoimmune disorders associated with high igg and / or tnf-delta or for potentiation of vaccine protocols, and method for treating sickness associated with immune dysfunction in an animal
WO2021207213A3 (en) Methods to prevent sars-cov-2 infection and treat covid-19
NO996117L (en) Device for administering medications and treating viral and microbial infections and taering syndrome
DE69929616D1 (en) OXYHUMIC ACID AND ITS USE FOR THE TREATMENT OF DIFFERENT DISORDER
BRPI0412924A (en) preoperative treatment of postoperative pain
BR0209985A (en) Compound and method for treating a patient
SE9700244D0 (en) Novel antibacterial protein
Trevisani et al. Evaluation of a new ultrashort triple therapy for Helicobacter pylori disease
DE69810474D1 (en) MEDICAL COMPOSITIONS AGAINST HELICOBACTER PYLORI
PT1156795E (en) USE OF SUCCINIC ACID OR ITS SALTS AND METHOD OF TREATING INSULIN RESISTANCE
NO20006161D0 (en) Topical administration of oxazolidinones for transdermal delivery

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application